OR10H2 Inhibitors
OR10H2 inhibitors refer to a class of chemical compounds that specifically target the OR10H2 receptor, a member of the olfactory receptor family. Olfactory receptors are part of the G-protein-coupled receptor (GPCR) superfamily, which play critical roles in detecting and transducing chemical signals. OR10H2 belongs to a subset of receptors that are involved in the perception of specific odorants. When a ligand binds to this receptor, a conformational change occurs, activating a signal transduction pathway that ultimately leads to the perception of a smell. Inhibitors of OR10H2 work by obstructing the binding site or interfering with the signaling cascade, thereby preventing the receptor from interacting with its ligand. This mechanism is of particular interest in understanding the molecular dynamics of odorant recognition and the selective inhibition of olfactory receptors.
Chemically, OR10H2 inhibitors can vary in structure, but they generally share certain features that enable them to effectively bind to and inhibit the OR10H2 receptor. These compounds often mimic the structure of natural ligands, allowing them to compete for receptor binding. Others may act allosterically, binding to different parts of the receptor and inducing conformational changes that reduce its activity. Research into the molecular interactions between OR10H2 and its inhibitors can provide valuable insights into the structural and functional aspects of this receptor. This line of investigation could shed light on broader olfactory processes, contributing to our understanding of GPCR-related signaling pathways, receptor-ligand specificity, and the chemistry of molecular inhibition within the olfactory system.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A could downregulate OR10H2 by inhibiting histone deacetylase activity, leading to a condensed chromatin state and reduced transcriptional access to the OR10H2 gene locus. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
By inhibiting DNA methyltransferase, 5-Azacytidine might decrease methylation levels at the OR10H2 promoter, potentially leading to the suppression of OR10H2 expression. | ||||||
Rifampicin | 13292-46-1 | sc-200910 sc-200910A sc-200910B sc-200910C | 1 g 5 g 100 g 250 g | $97.00 $328.00 $676.00 $1467.00 | 6 | |
Rifampicin could decrease the synthesis of OR10H2 mRNA by inhibiting the bacterial RNA polymerase that may be used in a heterologous expression system for OR10H2. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Actinomycin D might inhibit the transcription of OR10H2 by binding to DNA at the transcription initiation complex and preventing the elongation of RNA chains. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
Camptothecin could lead to a decrease in OR10H2 expression by stabilizing the DNA-topoisomerase I complex during transcription, causing DNA damage and halting transcriptional processes. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine may downregulate OR10H2 by intercalating into the DNA of the OR10H2 gene, which could obstruct the transcription machinery and decrease gene expression. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
α-Amanitin could inhibit RNA polymerase II activity, leading to a decrease in the transcription of genes, including OR10H2, thereby reducing its mRNA and protein levels. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium Butyrate might reduce OR10H2 expression by hyperacetylating histones around the OR10H2 gene promoter, which could lead to an inaccessible chromatin structure for the transcription machinery. | ||||||
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $55.00 | 6 | |
Mithramycin A could bind to G-C-rich DNA sequences within the OR10H2 promoter region, potentially displacing necessary transcription factors and decreasing OR10H2 transcription. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
DRB might inhibit the phosphorylation of the C-terminal domain of RNA polymerase II, leading to reduced transcription elongation efficiency and thereby decreasing OR10H2 expression. | ||||||